J 2022

Phosphorylated and Phosphomimicking Variants May Differ—A Case Study of 14-3-3 Protein

KOZELEKOVÁ, Aneta, Alexandra NÁPLAVOVÁ, Tomáš BROM, Norbert GAŠPARIK, Jan ŠIMEK et. al.

Basic information

Original name

Phosphorylated and Phosphomimicking Variants May Differ—A Case Study of 14-3-3 Protein

Authors

KOZELEKOVÁ, Aneta (203 Czech Republic, belonging to the institution), Alexandra NÁPLAVOVÁ (203 Czech Republic, belonging to the institution), Tomáš BROM (203 Czech Republic, belonging to the institution), Norbert GAŠPARIK (703 Slovakia, belonging to the institution), Jan ŠIMEK (203 Czech Republic, belonging to the institution), Josef HOUSER (203 Czech Republic, belonging to the institution) and Jozef HRITZ (703 Slovakia, guarantor, belonging to the institution)

Edition

Frontiers in Chemistry, Frontiers Media SA, 2022, 2296-2646

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

10608 Biochemistry and molecular biology

Country of publisher

Switzerland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 5.500

RIV identification code

RIV/00216224:14740/22:00119696

Organization unit

Central European Institute of Technology

UT WoS

000777334200001

Keywords in English

14-3-3; phosphorylation; phosphomimicking mutation; oligomeric state; dissociation constant

Tags

International impact, Reviewed
Změněno: 27/10/2024 15:22, Ing. Martina Blahová

Abstract

V originále

Protein phosphorylation is a critical mechanism that biology uses to govern cellular processes. To study the impact of phosphorylation on protein properties, a fully and specifically phosphorylated sample is required although not always achievable. Commonly, this issue is overcome by installing phosphomimicking mutations at the desired site of phosphorylation. 14-3-3 proteins are regulatory protein hubs that interact with hundreds of phosphorylated proteins and modulate their structure and activity. 14-3-3 protein function relies on its dimeric nature, which is controlled by Ser58 phosphorylation. However, incomplete Ser58 phosphorylation has obstructed the detailed study of its effect so far. In the present study, we describe the full and specific phosphorylation of 14-3-3ζ protein at Ser58 and we compare its characteristics with phosphomimicking mutants that have been used in the past (S58E/D). Our results show that in case of the 14-3-3 proteins, phosphomimicking mutations are not a sufficient replacement for phosphorylation. At physiological concentrations of 14-3-3ζ protein, the dimer-monomer equilibrium of phosphorylated protein is much more shifted towards monomers than that of the phosphomimicking mutants. The oligomeric state also influences protein properties such as thermodynamic stability and hydrophobicity. Moreover, phosphorylation changes the localization of 14-3-3ζ in HeLa and U251 human cancer cells. In summary, our study highlights that phosphomimicking mutations may not faithfully represent the effects of phosphorylation on the protein structure and function and that their use should be justified by comparing to the genuinely phosphorylated counterpart.

Links

EF18_046/0015974, research and development project
Name: Modernizace České infrastruktury pro integrativní strukturní biologii
GF20-05789L, research and development project
Name: Charakterizace přirozeně neuspořádaných proteinů
Investor: Czech Science Foundation, Partner Agency (Austria)
MUNI/C/1562/2019, interní kód MU
Name: Studium struktury a interakcí fosforylovaného 14-3-3 proteinu
Investor: Masaryk University, Rector's Program
90127, large research infrastructures
Name: CIISB II
90129, large research infrastructures
Name: Czech-BioImaging II